NIKKEI 225
29,683.09 +84.43 (+0.29%) HANG SENG
25,319.72 -330.36 (-1.29%) GOLD FUTURES
1,861.20 -0.20 (-0.01%) DOW
35,870.95 -60.10 (-0.17%) BTC-GBP
43,101.20 +2,275.60 (+5.57%) CMC Crypto 200
1,402.14 -65.80 (-4.48%)
Valbiotis SA (ALVAL.PA)
| Previous close | 7.00 |
| Open | 6.96 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 6.90 - 6.99 |
| 52-week range | 5.84 - 8.38 |
| Volume | 5,078 |
| Avg. volume | 7,299 |
| Market cap | 66.9M |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.51 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Valbiotis Announces Positive Preclinical Results for TOTUM•070 in Hypercholesterolemia, Selected and Presented at the American Heart Association (AHA) Annual Meeting
LA ROCHELLE, France, November 15, 2021--Valbiotis announces positive preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at AHA annual meeting
- Business Wire
Valbiotis Reviews Its Activities and Publishes Its Financial Report for the First Half of 2021
LA ROCHELLE, France, September 30, 2021--Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible) (Paris:ALVAL), a French research and development company committed to scientific innovation for preventing and combating metabolic diseases, publishes its financial report for the first half of 2021 and provides an update on the Company's progress.
- Business Wire
Valbiotis Consolidates Its Development of Innovative Natural Health Solutions by Integrating the Exploration of Microalgae Produced in New Caledonia, Through an Exclusive Agreement With ADECAL-Technopole and IFREMER
LA ROCHELLE, France, September 24, 2021--Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible), a French research and development company committed to scientific innovation for preventing and combating of metabolic diseases, announces the consolidation of its development of innovative natural health solutions, by integrating the exploration of microalgae produced in New Caledonia, through an exclusive agreement with ADECAL-Technopole and IFREMER. This program should allow to develo
